MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells

Molecular and Cellular Endocrinology

Volumn 404, Issue , 2015, Pages 113-122

  Kalhori, Veronica ^a,b   Törnquist, Kid ^a,b  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

Calpain; Migration and invasion; MMP2; MMP9; Sphingosine 1 phosphate; Thyroid cancer

Indexed keywords

CALPAIN; GELATINASE A; GELATINASE B; RAC1 PROTEIN; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; LYSOPHOSPHOLIPID; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; RAC1 PROTEIN, HUMAN; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ARTICLE; CANCER CELL; CANCER CELL LINE; CANCER INHIBITION; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; ML 1 CELL LINE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THYROID CANCER; THYROID FOLLICLE CELL; TUMOR INVASION; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; CELL MOTION; ENZYMOLOGY; METABOLISM; PATHOLOGY; SECRETION (PROCESS); THYROID TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA, FOLLICULAR; CALPAIN; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RAC1 GTP-BINDING PROTEIN; SPHINGOSINE; THYROID NEOPLASMS;

EID: 84922439922     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.01.037     Document Type: Article

References (27)

1. Balthasar S., Bergelin N., Lof C., Vainio M., Andersson S., Tornquist K. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. Endocr. Relat. Cancer 2008, 15:521-534.
2. Balthasar S., Samulin J., Ahlgren H., Bergelin N., Lundqvist M., Toescu E.C., et al. Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Biochem. J. 2006, 398:547-556.
3. Bergelin N., Blom T., Heikkila J., Lof C., Alam C., Balthasar S., et al. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2. Endocrinology 2009, 150:2055-2063.
4. Chen B., Tang J., Guo Y.S., Li Y., Chen Z.N., Jiang J.L. Calpains are required for invasive and metastatic potentials of human HCC cells. Cell Biol. Int 2013, 37:643-652.
5. Devine K.M., Smicun Y., Hope J.M., Fishman D.A. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. Gynecol. Oncol 2008, 110:237-245.
6. Folgueras A.R., Pendas A.M., Sanchez L.M., Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int. J. Dev. Biol 2004, 48:411-424.
7. Gingras D., Michaud M., Di Tomasso G., Beliveau E., Nyalendo C., Beliveau R. Sphingosine-1-phosphate induces the association of membrane-type 1 matrix metalloproteinase with p130Cas in endothelial cells. FEBS Lett 2008, 582:399-404.
8. Kalhori V., Kemppainen K., Asghar M.Y., Bergelin N., Jaakkola P., Tornquist K. Sphingosine-1-phosphate as a regulator of hypoxia-induced factor-1alpha in thyroid follicular carcinoma cells. PLoS ONE 2013, 8:e66189.
9. Kang H., Kwak H.I., Kaunas R., Bayless K.J. Fluid shear stress and sphingosine 1-phosphate activate calpain to promote membrane type 1 matrix metalloproteinase (MT1-MMP) membrane translocation and endothelial invasion into three-dimensional collagen matrices. J. Biol. Chem 2011, 286:42017-42026.
10. Kim E.S., Kim J.S., Kim S.G., Hwang S., Lee C.H., Moon A. Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Galphaq coupling. J. Cell Sci 2011, 124:2220-2230.
11. Kwak H.I., Kang H., Dave J.M., Mendoza E.A., Su S.C., Maxwell S.A., et al. Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation. Angiogenesis 2012, 15:287-303.
12. Mayorca-Guiliani A., Erler J.T. The potential for targeting extracellular LOX proteins in human malignancy. Onco Targets Ther 2013, 6:1729-1735.
13. Miller G.S., List K. The matriptase-prostasin proteolytic cascade in epithelial development and pathology. Cell Tissue Res 2013, 351:245-253.
14. Murali A., Rajalingam K. Small Rho GTPases in the control of cell shape and mobility. Cell. Mol. Life Sci 2014, 71:1703-1721.
15. Noh H., Hong S., Huang S. Role of urokinase receptor in tumor progression and development. Theranostics 2013, 3:487-495.
16. Pyne N.J., Pyne S. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 2010, 10:489-503.
17. Rajoria S., Suriano R., George A., Shanmugam A., Schantz S.P., Geliebter J., et al. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. PLoS ONE 2011, 6:e15879.
18. Romero Otero J., Garcia Gomez B., Campos Juanatey F., Touijer K.A. Prostate cancer biomarkers: an update. Urol. Oncol 2014, 32:252-260.
19. Schonberger J., Bauer J., Spruss T., Weber G., Chahoud I., Eilles C., et al. Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J. Mol. Med. (Berl.) 2000, 78:102-110.
20. Selvam S.P., Ogretmen B. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance. Handb. Exp. Pharmacol 2013, 216:3-27.
21. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol 2000, 10:415-433.
22. Storr S.J., Carragher N.O., Frame M.C., Parr T., Martin S.G. The calpain system and cancer. Nat. Rev. Cancer 2011, 11:364-374.
23. Sun H.Y., Wei S.P., Xu R.C., Xu P.X., Zhang W.C. Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis. Biochem. Biophys. Res. Commun 2010, 395:361-366.
24. Törnquist K. Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells. Acta Physiol. (Oxf.) 2012, 204:151-157.
25. Wu W.T., Chen C.N., Lin C.I., Chen J.H., Lee H. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 2005, 146:3387-3400.
26. Yang Q., Ji M., Guan H., Shi B., Hou P. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. J. Clin. Endocrinol. Metab 2013, 98:E1909-E1917.
27. Zhang X.G., Lu X.F., Jiao X.M., Chen B., Wu J.X. PLK1 gene suppresses cell invasion of undifferentiated thyroid carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9. Exp. Ther. Med 2012, 4:1005-1009.